Amphastar P (AMPH) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $23.63 (-0.80%), Market cap $0.79B, P/E ratio 10.73, 52-week low–high $16.87 ~ $30.81.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for
Financial statements, price targets, institutional (13F) holdings and related news for Amphastar P are updated in real time on BlackAll Trade.
Amphastar P trades at $23.63 (-0.80%). Real-time quotes and charts are available on BlackAll Trade.
Amphastar P has a market cap of about $0.79B. Its P/E ratio is 10.73.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States,